可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure[J]. Eur Heart J, 1998, 19(7):990-1003.
[2] Marsozs SP, Griffin BP, Topal EJ. 心血管内科手册[M]. 陈灏珠,主译. 北京: 人民卫生出版社, 2001:148-149.
[3] Ommen SR. Echocardiographic assessment of diastolic function[J]. Curr Opin Cardiol, 2001, 16(4):240-245.
[4] 臧益民,朱妙章,袁丽君,等. 心脏功能无创伤检测的研究进展[J]. 心脏杂志, 2005, 17(3):292-306.
[5] Lenihan DJ, Gerson MC, Hoit BD, et al. Mechanisms, diagnosis, and treatment of diastolic heart failure[J]. Am Heart J, 1995, 130(1):153-166.
[6] Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEPCHF)study[J]. Eur Heart J, 2006, 27(19):2338-2345.
[7] 中华医学会心血管病分会,中华心血管病杂志编辑委员会.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J]. 中华心血管病杂志, 2007, 35(2):97-106.
[8] Daholf B, Sever P, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA): a multicentre randomized controlled trial[J]. Lancet, 2005, 366(9489):895-906.
[9] Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system[J]. Circulation, 1991, 83(6):1849-1865.